# Processa Pharmaceuticals, Inc.: Form 8-K, filed Feb 20, 2015

- Company: [Processa Pharmaceuticals, Inc.](/companies/pcsa.md) (CIK 1533743)
- Form: 8-K
- Filed: 2015-02-20
- Accepted by EDGAR: Feb 20, 2015, 16:47 ET
- Period: 2015-02-16
- Accession: 0001393905-15-000075
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1533743/000139390515000075/huwx_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1533743/000139390515000075/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.03: New direct financial obligation
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1533743/000139390515000075/huwx_8k.htm

Filed Feb 20, 2015.
Source: SEC EDGAR, the filing index for accession 0001393905-15-000075. Last ingested by Listed: Nov 14, 2026, 23:30 ET. No prices; not investment advice.
